Nouvelle déclaration d'incident
No de la demande: 2021-6433
Numéro de référence du titulaire d'homologation: 2021-US-045350
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G 5L3
Incident chez un animal domestique
Pays: UNITED STATES
État: IOWA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2724-404
Nom du produit: Zoecon Petcor Flea Spray Dogs, Puppies, Cats and Kittens
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Cat / Chat
Ragdoll
1
Homme
1
5.443
kg
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 01 Oct 2021, the animal owner applied the product to the cat with a gloved hand. The cat had a history of intermittent vomiting. On 02 Oct 2021 the cat vomited a larger amount than he normally does. On 03 Oct 2021, the cat developed vocalization and panting. Animal owners veterinarian recommended administration of aspirin, but it was unclear whether aspirin was administered or not. The cat developed congestion and was transported toward the veterinary clinic. The cat died on the way to the clinic. No further information is expected.
Mort
Assessment: This product has a wide margin of safety. Mild dermal irritation is possible following topical use. If ingested, mild self-limiting GI irritation leading to vomiting may occur. Delayed onset of vocalization and respiratory signs two days after product administration are not expected. Other causes including underlying respiratory and cardiac disease should be considered. Veterinary examination and diagnostics including necropsy may have been able to provide further information about the cause of the clinical signs and death, but these were not pursued. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.